top of page


Cancer52 announces new Chair of the Board
We are delighted to announce that Anne MacDowell has joined Cancer52 as Chair of the Board. Anne brings a wealth of experience to the...
Cancer52 response to the Major Conditions Strategy Strategic Framework
September 2023 The Department for Health and Social Care (DHSC) published an interim case for change and strategic framework as part of...


Worldwide Cancer Research is Cancer52's latest member
Worldwide Cancer Research is the newest member of Cancer52! Worldwide Cancer Research starts new cures by funding pioneering discovery...


Cancer52 analysis on rare and less common cancer research spend
Cancer52 and the National Cancer Research Institute (NCRI) joined forces to create a report titled: Research into rare and less common...


Ruth Strauss Foundation joins Cancer52
Cancer52 are delighted to welcome our newest member, the Ruth Strauss Foundation, We are now 113 members strong! Former England cricket...

The Big Cancer52 Conversation
Cancer52 hosted The Big Cancer52 Conversation on Wednesday 14th June 2023, supported by The Cancer Awareness Trust and Level39 at Canary...


Second fundraiser planned for Lucien
Two years ago, Lucien Seller died aged just 25 of a rare thymic cancer. This Saturday 13th May 2023 his colleagues at Buzz Parks...

Swallows are a member of Cancer52
We're delighted to have Swallows Head & Neck Cancer Charity as a Cancer52 member. The charity’s intention is for every person affected by...
Cancer52 Fair Market Value survey results
Cancer52 has worked in partnership with the Patient Information Forum (PIF) and National Rheumatoid Arthritis Society (NRAS) to conduct a...
A joint statement on the voluntary scheme for branded medicines pricing and access (VPAS)
Patient charities set out a shared vision for the next VPAS scheme. Cancer52 have joined forces with the Charity Medicines Access...
bottom of page